Date: 16th November, 2026

Financial Performance Summary

Q2 FY27 Financial Highlights (₹ in Lakhs)

| Particulars | Q2 FY25–26 | Q2 FY26–27 | YoY Growth |

| TOTAL REVENUE | 10,575.75 | 13,937.33 | +31.79% |

| OPERATING EBITDA* (BEFORE PROVISION FOR ESOP) | 1,576.77 | 1,583.54 | +0.43% |

| OPERATING PAT* (BEFORE PROVISION FOR ESOP) | 1,141.67 | 1,196.21 | +4.78% |

*Note: Operating EBITDA (Before Provision for ESOP) and PAT (Before Provision for ESOP) exclude non-cash, equity-settled ESOP compensation charges recognized under Ind AS 102. Before Provision for ESOP is a non-cash book entry under Ind AS 102 (credited to Other Equity) and does not involve any cash outflow.

H1 FY27 Financial Performance

  • H1 FY27 Revenue: ₹26,404.90 lakh, representing +22.1% YoY growth
  • H1 Operating PAT (Before Provision for ESOP): ₹3,052.78 lakh, representing +40.2% YoY growth

ESOP Accounting Impact

  • The company recognized a non-cash ESOP charge under Ind AS 102 for 15,86,505 employee stock options
  • Zero cash outflow: This is a non-cash equity-settled employee compensation charge with no payment or expense by the company
  • Management emphasizes that adjusted metrics isolate underlying operating profitability and statutory filings remain fully compliant with Ind AS 102

Strategic Business Updates

Khalapur High-Purity Helium Facility

  • The Khalapur Helium Facility is fully operational and meeting expected volumes for the year
  • Entry into high-value specialty gases targeting semiconductors, MRI healthcare, aerospace, and defence markets
  • Established global supply alliance with SOC Dubai & Qatar for sourcing partnerships

Capacity Expansion Projects

1. Specialty Gases: Scaling high-purity semiconductor gas supply through Khalapur Helium ramp-up

2. New Facility: Mambattu expansion strengthening regional manufacturing and reach

3. Next-Gen Molecules: R-32 projects driving backward integration and portfolio depth

Management Commentary

Mr. Shazad Rustomji, Chairman & Managing Director, stated: "We delivered a steady performance during H1 FY27, supported by our established operations, diversified portfolio, and expanding market presence. Our Khalapur Helium facility marks a key milestone in high-value specialty gases as we advance Mambattu, R‑32, and HFO projects."

Company Background

  • Established in 1992 with 30+ years in refrigerants and industrial gases
  • Operates 5 strategic plants across Khalapur, Ghiloth, Manesar, and Panvel facilities
  • Specializes in custom HC and HFO formulations serving HVAC, pharma, automotive, glass, and semiconductor industries

Investor Relations

Investor Relations Contact: ConfideLeap Partners